FDA Drug Application (091636) for ALYACEN 7/7/7 by GLENMARK GENERICS

Back to FDA Applications sponsored by GLENMARK GENERICS

Application Number091636
Product Number001
FormTABLET;ORAL-28
Dosage0.035MG,0.035MG,0.035MG;0.5MG,0.75MG,1MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameALYACEN 7/7/7
Active IngredientETHINYL ESTRADIOL; NORETHINDRONE

Active IngredientCount
List of drugs with Active Ingredient ETHINYL ESTRADIOL226
List of drugs with Active Ingredient NORETHINDRONE82


Back to FDA Applications sponsored by GLENMARK GENERICS